122 related articles for article (PubMed ID: 37730133)
1. Interplay between SUMO1-related SUMOylation and phosphorylation of p65 promotes hepatocellular carcinoma progression.
Jiang C; Zhang C; Dai M; Wang F; Xu S; Han D; Wang Y; Cao Y; Liang Y; Zhang Z; Yan L; Shen Y; He K; Shen Y; Liu J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119595. PubMed ID: 37730133
[TBL] [Abstract][Full Text] [Related]
2. Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation.
Liu J; Tao X; Zhang J; Wang P; Sha M; Ma Y; Geng X; Feng L; Shen Y; Yu Y; Wang S; Fang S; Shen Y
Oncotarget; 2016 Apr; 7(16):22206-18. PubMed ID: 26993772
[TBL] [Abstract][Full Text] [Related]
3. Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.
Liu J; Sha M; Wang Q; Ma Y; Geng X; Gao Y; Feng L; Shen Y; Shen Y
BMC Cancer; 2015 Oct; 15():675. PubMed ID: 26458400
[TBL] [Abstract][Full Text] [Related]
4. Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-κB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.
Liu J; Wu Z; Han D; Wei C; Liang Y; Jiang T; Chen L; Sha M; Cao Y; Huang F; Geng X; Yu J; Shen Y; Wang H; Feng L; Wang D; Fang S; Wang S; Shen Y
Hepatology; 2020 Apr; 71(4):1262-1278. PubMed ID: 31469428
[TBL] [Abstract][Full Text] [Related]
5. Sumoylation in liver disease.
Zeng M; Liu W; Hu Y; Fu N
Clin Chim Acta; 2020 Nov; 510():347-353. PubMed ID: 32710938
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.
Zhang M; Zhang H; Cheng S; Zhang D; Xu Y; Bai X; Xia S; Zhang L; Ma J; Du M; Wang Y; Wang J; Chen M; Leng J
Tumour Biol; 2014 Jul; 35(7):7135-45. PubMed ID: 24760275
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
[TBL] [Abstract][Full Text] [Related]
8. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.
Xu H; Wang H; Zhao W; Fu S; Li Y; Ni W; Xin Y; Li W; Yang C; Bai Y; Zhan M; Lu L
Theranostics; 2020; 10(13):5671-5686. PubMed ID: 32483411
[No Abstract] [Full Text] [Related]
9. SUMOylated CPAP is required for IKK-mediated NF-κB activation and enhances HBx-induced NF-κB signaling in HCC.
Yang ST; Yen CJ; Lai CH; Lin YJ; Chang KC; Lee JC; Liu YW; Chang-Liao PY; Hsu LS; Chang WC; Hung WC; Tang TK; Liu YW; Hung LY
J Hepatol; 2013 Jun; 58(6):1157-64. PubMed ID: 23369793
[TBL] [Abstract][Full Text] [Related]
10. SUMOylation attenuates the transcriptional activity of the NF-κB subunit RelB.
Leidner J; Voogdt C; Niedenthal R; Möller P; Marienfeld U; Marienfeld RB
J Cell Biochem; 2014 Aug; 115(8):1430-40. PubMed ID: 24616021
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma.
Qin Y; Bao H; Pan Y; Yin M; Liu Y; Wu S; Li H
Mol Med Rep; 2014 Mar; 9(3):877-81. PubMed ID: 24399357
[TBL] [Abstract][Full Text] [Related]
12. Ginkgoic acid impedes gastric cancer cell proliferation, migration and EMT through inhibiting the SUMOylation of IGF-1R.
Liu D; Li Z; Yang Z; Ma J; Mai S
Chem Biol Interact; 2021 Mar; 337():109394. PubMed ID: 33508304
[TBL] [Abstract][Full Text] [Related]
13. High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells.
Huang W; Xu L; Zhou X; Gao C; Yang M; Chen G; Zhu J; Jiang L; Gan H; Gou F; Feng H; Peng J; Xu Y
Biochem Biophys Res Commun; 2013 Aug; 438(3):568-74. PubMed ID: 23911785
[TBL] [Abstract][Full Text] [Related]
14. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the interactions of HIV-1 integrase with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
Li Z; Wu S; Wang J; Li W; Lin Y; Ji C; Xue J; Chen J
Int J Mol Med; 2012 Nov; 30(5):1053-60. PubMed ID: 22895527
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target.
Xu X; Lei Y; Chen L; Zhou H; Liu H; Jiang J; Yang Y; Wu B
J Exp Clin Cancer Res; 2021 Aug; 40(1):253. PubMed ID: 34380537
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation of HSP27 by small ubiquitin-like modifier 2/3 promotes proliferation and invasion of hepatocellular carcinoma cells.
Ge H; Du J; Xu J; Meng X; Tian J; Yang J; Liang H
Cancer Biol Ther; 2017 Aug; 18(8):552-559. PubMed ID: 28665748
[TBL] [Abstract][Full Text] [Related]
18. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
19. SUMO E3 Ligase PIASy Mediates High Glucose-Induced Activation of NF-
Huang W; Liang Y; Dong J; Zhou L; Gao C; Jiang C; Chen M; Long Y; Xu Y
Mediators Inflamm; 2017; 2017():1685194. PubMed ID: 29038616
[TBL] [Abstract][Full Text] [Related]
20. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
